HomeLRMR • NASDAQ
add
Larimar Therapeutics Inc
Previous close
$4.17
Day range
$3.90 - $4.17
Year range
$1.61 - $9.50
Market cap
336.37M USD
Avg Volume
1.59M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 27.79M | 12.98% |
Net income | -26.18M | -21.06% |
Net profit margin | — | — |
Earnings per share | -0.41 | -20.59% |
EBITDA | -27.70M | -13.03% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 138.52M | -38.72% |
Total assets | 149.99M | -36.76% |
Total liabilities | 30.13M | 16.99% |
Total equity | 119.85M | — |
Shares outstanding | 85.59M | — |
Price to book | 2.23 | — |
Return on assets | -43.40% | — |
Return on capital | -50.79% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -26.18M | -21.06% |
Cash from operations | -19.38M | -38.55% |
Cash from investing | 18.84M | 129.68% |
Cash from financing | — | — |
Net change in cash | -539.00K | 99.31% |
Free cash flow | -10.06M | -54.31% |
About
Founded
2005
Headquarters
Website
Employees
65
